The laboratory core will be an integral component of our center of excellence in malaria research. It will act as a central store and distribution center for all field surveillance activities. In addition, it will directly serve research project 1, 3, and 4. The core will consist of two established laboratories, in Kampala and Tororo, which have capacity for the organization and storage of large numbers of samples, the culture of malaria parasites, the collection of blood components for immunological assays, and molecular studies to assess mediators of drug and insecticide resistance.
The aims of the laboratory core will be: (1) to serve as a central repository for the distribution of supplies to surveillance sites and the collection, collation, and storage of samples from surveillance sites, (2) to support laboratory components of surveillance activities, (3) to support immunology studies related to surveillance activities, and (4) to support studies of parasite resistance to antimalarials and mosquito resistance to insecticides. Our surveillance will include extensive collection of blood spots on filter paper and trapped mosquitoes, which will be stored at our central laboratory in Kampala We will use these samples to perform regular surveillance in Kampala for immune responses to P. falciparum, for P. falciparum polymorphisms known or predicted to be associated with drug resistance, for mosquito infection with P. falciparum, and for mosquito polymorphisms and metabolic changes associated with insecticide resistance. Our Tororo laboratory will provide serum and parasite samples from members of our cohorts at that site for analysis in Projects 3 and 4. Serum samples will allow us to characterize relationships between parasite exposure, the immune response, and protection from infection and disease. Parasite samples will allow us to serially evaluate the drug sensitivity of parasites from members of our cohorts, allowing us to search for associations between parasite sensitivity to drugs, clinical outcomes after treatment or preventive therapy with these drugs, and molecular markers of drug resistance.

Public Health Relevance

Laboratory studies are an important component of assessments of malaria. Our laboratory core in Uganda will conduct studies to assess the drug resistance of malaria parasites, insecticide resistance of malaria transmitting mosquitoes, and antimalarial immune responses of people living in regions of Uganda with varied levels of transmission of malaria.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI089674-04
Application #
8501294
Study Section
Special Emphasis Panel (ZAI1-AWA-M)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
4
Fiscal Year
2013
Total Cost
$126,875
Indirect Cost
$13,871
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Meerstein-Kessel, Lisette; Andolina, Chiara; Carrio, Elvira et al. (2018) A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes. Malar J 17:441
Glennon, Elizabeth K K; Megawati, Dewi; Torrevillas, Brandi K et al. (2018) Elevated plasma abscisic acid is associated with asymptomatic falciparum malaria and with IgG-/caspase-1-dependent immunity in Plasmodium yoelii-infected mice. Sci Rep 8:8896
James, W H M; Tejedor-Garavito, N; Hanspal, S E et al. (2018) Gridded birth and pregnancy datasets for Africa, Latin America and the Caribbean. Sci Data 5:180090
Utazi, C Edson; Sahu, Sujit K; Atkinson, Peter M et al. (2018) Geographic coverage of demographic surveillance systems for characterising the drivers of childhood mortality in sub-Saharan Africa. BMJ Glob Health 3:e000611
Isaacs, Alison T; Mawejje, Henry D; Tomlinson, Sean et al. (2018) Genome-wide transcriptional analyses in Anopheles mosquitoes reveal an unexpected association between salivary gland gene expression and insecticide resistance. BMC Genomics 19:225
Wesolowski, Amy; Winter, Amy; Tatem, Andrew J et al. (2018) Measles outbreak risk in Pakistan: exploring the potential of combining vaccination coverage and incidence data with novel data-streams to strengthen control. Epidemiol Infect 146:1575-1583
Weetman, David; Wilding, Craig S; Neafsey, Daniel E et al. (2018) Candidate-gene based GWAS identifies reproducible DNA markers for metabolic pyrethroid resistance from standing genetic variation in East African Anopheles gambiae. Sci Rep 8:2920
Rodriguez-Barraquer, Isabel; Arinaitwe, Emmanuel; Jagannathan, Prasanna et al. (2018) Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure. Elife 7:
Nankabirwa, Joaniter I; Briggs, Jessica; Rek, John et al. (2018) Persistent parasitemia despite dramatic reduction in malaria incidence after 3 rounds of indoor residual spraying in Tororo, Uganda. J Infect Dis :
Rek, John C; Alegana, Victor; Arinaitwe, Emmanuel et al. (2018) Rapid improvements to rural Ugandan housing and their association with malaria from intense to reduced transmission: a cohort study. Lancet Planet Health 2:e83-e94

Showing the most recent 10 out of 172 publications